Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373

SK bioscience submits application for NVX-CoV2373, the first protein-based COVID-19 vaccine candidate for BLA, to South Korea’s MFDS Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited (SK bioscience), a biotechnology company in South Korea, today announced the submission of a Biologics […]

thaipr.net

16 พ.ย. 64

AstraZeneca discloses the making and quality assuring of COVID-19 vaccine manufactured in Thailand

The Emergency Use Listing (EUL) authorisation has recently been granted by the World Health Organization (WHO) to AstraZeneca’s COVID-19 vaccine manufactured in Thailand by Siam Bioscience and recognises that COVID-19 Vaccine AstraZeneca or Vaxzevria is the same product wherever it is made. AstraZeneca today reveals manufactured by its production partner in Thailand Siam Bioscience who […]

thaipr.net

15 พ.ย. 64

Ascensia Diabetes Care Announce Winner of This is Diabetes Art and Photo Competition

Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR® blood glucose monitoring (BGM) system portfolio and distributors of the Eversense® continuous glucose monitoring (CGM) system, has announced the winner of its This is Diabetes art and photo competition. The competition was looking for a piece of artwork or photography that reflected “Access to Diabetes Care”, […]

thaipr.net

15 พ.ย. 64

Jubilant Biosys Limited Announces New Chemistry Innovation Research Center to Support Expanded Discovery Chemistry and in-vitro ADME Services for Clients like Turning Point Therapeutics

Jubilant Biosys Limited announced today, an expansion of its facilities to support its discovery chemistry and in-vitro ADME Service offerings. Jubilant Biosys provides services for Turning Point Therapeutics Inc. for multiple small molecule oncology research programs. Turning Point is a precision oncology company developing next-generation therapies that target genetic drivers of cancer. Services for Turning Point Therapeutics Inc. […]

thaipr.net

15 พ.ย. 64

Lianhua Qingwen Sent to People for Covid-19 Containment by Cambodian Government

On Sunday, 600 local families in Veal Veaeng District, Pursat Province, Cambodia, got Lianhua Qingwen Capsules, produced by Yiling Pharmaceutical, from Suy Sem, the Cambodian Minister of Mines and Energy, also president of the Cambodian central government’s assisting team to Pursat Province. Local government officials like Cheav Tay, Governor of Pursat Province were also present to help […]

thaipr.net

11 พ.ย. 64

Ceres Nanosciences Establishes Nine Wastewater-based COVID-19 Surveillance Centers of Excellence Under NIH RADx Initiative

Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of nine wastewater-based epidemiology centers of excellence, as part of the April 2021 $8.2 million award from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. Wastewater-based epidemiology can help communities […]

thaipr.net

10 พ.ย. 64

RedHill Biopharma and South Korea’s Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill

RedHill received the first tranche of $5 million in a private placement of restricted stock priced at $6.04 per ADS, representing a 20% premium based on the 30 trading days’ volume weighted average price (VWAP) ending on the effective date RedHill granted Kukbo a right of first offer for opaganib, RHB-107 (upamostat) and Talicia® for South Korea […]

thaipr.net

9 พ.ย. 64
1 89 90 91 92 93 128